FARALLON CAPITAL MANAGEMENT LLC - Q2 2016 holdings

$7.27 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 64 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .

 Value Shares↓ Weighting
STJ NewST JUDE MED INC$358,800,0004,600,000
+100.0%
4.93%
CHTR NewCHARTER COMMUNICATIONS INC Ncl a$240,384,0001,051,366
+100.0%
3.30%
LNKD NewLINKEDIN CORP$174,110,000920,000
+100.0%
2.39%
GD NewGENERAL DYNAMICS CORP$91,787,000659,198
+100.0%
1.26%
EXEL NewEXELIXIS INC$38,386,0004,915,000
+100.0%
0.53%
MON NewMONSANTO CO NEW$23,267,000225,000
+100.0%
0.32%
LILA NewLIBERTY GLOBAL PLC$14,733,000456,700
+100.0%
0.20%
WR NewWESTAR ENERGY INC$13,647,000243,300
+100.0%
0.19%
NewTIVO INCnote 2.000%10/0$11,566,00011,759,000
+100.0%
0.16%
IOC NewINTEROIL CORP$10,575,000235,000
+100.0%
0.14%
TIVO NewTIVO INC$9,900,0001,000,000
+100.0%
0.14%
BCE NewBCE INC$6,323,000133,650
+100.0%
0.09%
PLCM NewPOLYCOM INC$4,725,000420,000
+100.0%
0.06%
MITL NewMITEL NETWORKS CORP$4,322,000687,100
+100.0%
0.06%
RAD NewRITE AID CORP$3,535,000472,022
+100.0%
0.05%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR2024-05-15
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export FARALLON CAPITAL MANAGEMENT LLC's holdings